Abstract:Radiation-induced lung toxicity (RILT) is an important dose-limiting toxicity during thoracic radiation therapy. The purpose of this study is to investigate perfusion (Q) single-photon emission computerized tomography (SPECT)-weighted functional dose-volume histogram (FDVH) during the course of radiation therapy (RT) for predicting RILT in patients with non-small-cell lung cancer (NSCLC). (This study is supported by NSFC81172133 and NSFC81372413) Fifteen locally advanced NSCLC patients were enrolled prospectively. All patients were treated with definitive RT 60Gy and concurrent cisplatin based chemotherapy. The simulation computerized tomography (CT), Q-SPECT-CT were performed prior to and during RT at approximately 45 Gy. The RT plans really performed were generated only from the simulation CT 3 days before treatment and three dimensional conformal radiation therapy (3D CRT) or intensity modulated radiation therapy techniques (IMRT) were used according to clinical need. Functional lung was weighted by the 99m-technetium (99m-Tc)-labeled macro aggregated albumin (MAA) SPECT lung perfusion beyond a threshold of 30% of the maximum radioactivity. The baseline dose-volume histogram (baseline-DVH) based on baseline simulation CT, during-DVH based on during-RT, baseline functional lung DVH (baseline-FDVH) and during-FDVH were calculated respectively. The RILT grade was defined according to the National Cancer Institute Common Toxicity Criteria, version 4.0. The development of RILT was considered as a binary variable: “no-RILT” (Grade≥1) and “RILT” (Grade≥2). The predictive abilities of baseline-DVH, during-DVH, baseline-FDVH, and during-FDVH were calculated and compared based on the area under receiver operating characteristic (ROC) curve (AUC). The accumulative incidence of ≥ 2 grade RILT was 46.7% with a median follow-up of 6 months. Univariate analysis showed that the standard (V5–V20) and functional (FV5–FV20) parameters, the mean lung dose (MLD) and functional MLD (FMLD) were associated with RILT (all value of P < 0.05). By ROC curve analysis, the AUCs of baseline-DVH metrics were 0.821-0.857, the AUCs of during-DVH metrics were 0.857-0.893, the AUCs of baseline-FDVH metrics were 0.821-0.911, and the AUCs of during-FDVH metrics were 0.839-0.964. These results indicated that the FDVH parameters seemed to add more predictive value than the DVH parameters; the parameters during RT seemed to add more predictive value than those based on baseline simulation CT or Q-SPECT-CT. The during-FDVH parameters showed the best predictive value. For example, during-RT FV10’s AUCs in predicting RILT was 0.964 that of V10 prior to RT was 0.857. During-FDVH parameters based on the Q-SPECT-CT are identified as reliable predictors for RILT, and may guide RT plan modification in patients with NSCLC.

Functional Dosimetric Metrics During the Mid-Course of Radiation Therapy May Predict Radiation-Induced Lung Toxicity Better in Patients with Non-Small Cell Lung Cancer

The Lungs Were on Fire: a Pilot Study of 18F-FDG PET/CT in Idiopathic-Inflammatory-myopathy-related Interstitial Lung Disease

A pilot study of function-based radiation therapy planning for lung cancer using hyperpolarized xenon-129 ventilation MRI

Predicting Severe Radiation Pneumonitis in Patients with Locally- Advanced Non-Small Cell Lung Cancer after Thoracic Radiotherapy: Development and Internal Validation of a Nomogram Based on the Clinical, Hematological and Dose–volume Histogram Parameters

Risk Factors for Radiation Induced Lung Toxicity in Locally Advanced Non-Small Cell Lung Cancer Treated with Three-Dimensional Radiotherapy

Quantitative Study of Lung Perfusion SPECT Scanning and Pulmonary Function Testing for Early Radiation-Induced Lung Injury in Patients with Locally Advanced Non-Small Cell Lung Cancer.

Establishing a 4D-CT lung function related volumetric dose model to reduce radiation pneumonia

Intermediate Dose-Volume Parameters, Not Low-Dose Bath, Is Superior to Predict Radiation Pneumonitis for Lung Cancer Treated With Intensity-Modulated Radiotherapy

Weighted-Support Vector Machine Learning Classifier of Circulating Cytokine Biomarkers to Predict Radiation-Induced Lung Fibrosis in Non-Small-Cell Lung Cancer Patients

An 18F-FDG PET/CT and Mean Lung Dose Model to Predict Early Radiation Pneumonitis in Stage III Non-Small Cell Lung Cancer Patients Treated with Chemoradiation and Immunotherapy

Quantification of diffuse parenchymal lung disease in non-small cell lung cancer patients with definitive concurrent chemoradiation therapy for predicting radiation pneumonitis

Integration of dosimetric parameters, clinical factors, and radiomics to predict symptomatic radiation pneumonitis in lung cancer patients undergoing combined immunotherapy and radiotherapy

MRI-based ventilation and perfusion imaging to predict radiation-induced pneumonitis in lung tumor patients at a 0.35T MR-Linac

Baseline plasma proteomic analysis to identify biomarkers that predict radiation-induced lung toxicity in patients receiving radiation for non-small cell lung cancer.

P2-223: Analysis of Clinical and Dosimetric Factors Associated with Severe Radiation Pneumonitis in Locally Advanced Non–Small–Cell–Lung–Cancer Patients Treated with Concurrent Chemotherapy and Intensity–modulated Radiotherapy (IMRT)

CT ventilation image-guided helical Tomotherapy at sparing functional lungs for locally advanced lung cancer: analysis of dose-function metrics and the impact on pulmonary toxicity

(18)F-FDG Avid Volumes on Pre-Radiotherapy FDG PET As Boost Target Delineation in Non-Small Cell Lung Cancer.

Simple Factors Associated with Radiation-Induced Lung Toxicity after Stereotactic Body Radiation Therapy of the Thorax: A Pooled Analysis of 88 Studies

Role of 18FDG PET/CT Metabolic Parameters in Predicting Hematological Toxicity During Chemoradiotherapy for Locally Advanced Cervical Cancer

A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis